Description

There is on-going development of  generic EU CTD Dossier of Risedronate, tablets, 5/30/35 mg.



Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.


Risedronic acid (INN) or risedronate sodium (USAN, trade name Actonel) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.


More details at: http://www.rxlist.com/actonel-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 41
Contact Advertiser

Add comment

 
Related adverts
 

Phone number

Sorry, you need to register or login first.

Email

Sorry, you need to register or login first.

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favorites

Sorry, you need to register or login first.